Tags: Rocephin

Cervicitis

Description of Medical Condition An inflammation of the uterine cervix. • Infectious cervicitis may be caused by Chlamydia trachomatis, Neisseria gonorrhoeae, Mycoplasma genitalium, ureaplasmas, Herpes simplex or Trichomonas vaginalis. • Chronic cervicitis is characterized by inflammation of the cervix without an identified pathogen System(s) affected: Reproductive Genetics: N/A Incidence/Prevalence in USA: • Gonorrhea: 166/100,000; 2% of sexually active women < age 30 • Chlamydia: 290/100,000; 5-35% of women • Trichomonas: 1200/100,000; 5-25% of women Predominant age: Infectious cervicitis is most common in adolescents, but can be seen in women of any age Predominant sex: Female only Medical Symptoms and Signs of Disease • Mucopurulent (yellow) discharge from the cervix • Cervical …

Continue Reading...

Specific Anti-Infective Agents

Antibiotics Before prescribing a specific antibiotic, clinicians should be able to answer these questions: •  How does the antibiotic kill or inhibit bacterial growth? •  What are the antibiotic’s toxicities and how should they be monitored? •  How is the drug metabolized, and what are the dosing recommendations? Does the dosing schedule need to be modified in patients with renal dysfunction? •  What are the indications for using each specific antibiotic? •  How broad is the antibiotic’s antimicrobial spectrum? •  How much does the antibiotic cost? Clinicians should be familiar with the general classes of antibiotics, their mechanisms of action, and their major toxicities. The differences between the specific antibiotics in …

Continue Reading...

Antimicrobial therapy: general principles

A wide variety of antimicrobial agents is available to treat established infections caused by bacteria, fungi, viruses, or parasites. This section will cover the general principles of antimicrobial therapy and will also include illustrative clinical problems to emphasize proper decision-making in using antimicrobials. Determinants of Antimicrobial Efficacy Measurement of antimicrobial activity in vitro Susceptibility testing is indicated for any bacterial pathogen warranting chemotherapy. Drugs that irreversibly destroy the ability of an organism to replicate, and perhaps in the process destroy the structural integrity of the organism, are microbicidal. Drugs that reversibly impair replicating ability, with this function being restored when drug concentrations fall below critical inhibitory levels, are microbiostatic. In quantitative …

Continue Reading...

Ceftriaxone Sodium

• Ceftriaxone is a semisynthetic, third generation cephalosporin antibiotic. Uses Ceftriaxone is used for the treatment of bone and joint infections, endocarditis, intra-abdominal infections, meningitis and other CNS infections, otitis media, respiratory tract infections,septicemia, skin and skin structure infections, and urinary tract infections caused by susceptible bacteria. The drug also is used for the treatment of chancroid, gonorrhea and associated infections, pelvic inflammatory disease,infections caused by Neisseria meningitidis, infections caused by Shigella, and typhoid fever and other infections caused by Salmonella. In addition, ceftriaxone is used for the treatment of Lyme disease and for empiric anti-infective therapy in febrile neutropenic patients, and has been used for perioperative prophylaxis. Ceftriaxone has a …

Continue Reading...

Community-Acquired Pneumonia: Current Therapies

Overview Many highly effective agents are available for the treatment of bacterial community-acquired pneumonia (community-acquired pneumonia) and other community-acquire respiratory tract infections (RTIs). Currently marketed antibiotics for community-acquired pneumonia demonstrate similar efficacy rates in clinical trials, and these agents have generally achieved clinical symptom resolution in 85-95% of trial participants. The drugs differ mainly in their spectrum of activity (the organisms against which the agent is effective), side-effect profiles, dosing schedules, and dose form availability. Broad-spectrum antibiotics are effective against a wide range of pathogens; narrow-spectrum antibiotics tend to be efficacious against a narrower range of bacterial species, generally either gram-positive or gram-negative organisms.TABLE:Mechanisms of Resistance Against Select Antibacterial Classes, 2004 …

Continue Reading...

Buy Ceftriaxone, Omnicef (Cefdinir) No Prescription 300mg Tabs

Buy Ceftriaxone, Omnicef(Cefdinir) 300mg No Prescription Ceftriaxone (Omnicef) 300mg Tablets Low Price Online Ceftriaxone (Roche’s Rocephin, generics) is one of the most successful antibiotics on the market. The agent is a third-generation parenteral cephalosporin available for IV or IM administration that was first launched in 1982. Ceftriaxone (Omnicef) 300mg has been available generically in Europe since 2002. In 2000, Cubist Pharmaceuticals announced that it had acquired the rights to oral ceftriaxone and was developing an alternate oral formulation. However, the company discontinued development in 2004 after human clinical trials showed highly variable bioavailability of the drug when administered orally. Ceftriaxone (Omnicef) 300mg has demonstrated a broad spectrum of activity against gram-positive and gram-negative …

Continue Reading...

Cefotaxime.Ceftriaxone

Cefotaxime Cefotaxime (Abbott/Sanofi-Aventis’ Claforan, generics) is a third-generation, parenteral cephalosporin available for IV or intramuscular (IM) administration. Cefotaxime was first marketed in 1981 in the United States, where generic versions of the injection are now available. The agent is also marketed by Roche in Japan. Cefotaxime is indicated for the treatment of lower respiratory tract infections caused by S. pneumoniae and other streptococci, E. coli, K. pneumoniae and other Klebsiella species, H. influenzae (including ampicillin-resistant strains). Cefotaxime is stable in the presence of many β-lactamase enzymes, which effectively extends its spectrum of activity against a number of gram-positive and gram-negative bacteria that are resistant to penicillins and other cephalosporins. Clinical and …

Continue Reading...

Acute Exacerbations of Chronic Bronchitis: Current therapies

Overview Numerous highly effective pharmacological agents are available to treat acute exacerbations of chronic bronchitis (acute exacerbations of chronic bronchitis). TABLE:Pharmacological Management of Underlying Disease During an Acute Exacerbation of Chronic Bronchitis summarizes the general pharmacological agents and classes used to manage acute exacerbations of chronic bronchitis. The primary therapies used in acute exacerbations of chronic bronchitis treat the causative infection (antibiotics), relieve symptoms (bronchodilators), and treat the underlying inflammation (corticosteroids). TABLE :Current Therapies Used for Acute Exacerbations of Chronic Bronchitis summarizes the leading antibiotic therapies used to treat the infection. Most acute exacerbations of chronic bronchitis cases require empiric antibiotic therapy because of the difficulty in definitively distinguishing exacerbations of …

Continue Reading...

Price of Omnicef, Ceftriaxone (Cefdinir) Without Insurance 300mg Tabs

Rocephin   250 mg vials Rocephin   1 g vials Rocephin   2 g vials Powder for solution for injection or infusion Ceftriaxone (as hydrated disodium ceftriaxone) 1.  What Rocephin is and what it is used for Read indications for use if you want to order Ceftriaxone online Rocephin contains a medicine called ceftriaxone. This belongs to a group of medicines called antibiotics. Rocephin is used to treat infections caused by bacteria. It can be used to treat infections in different parts of the body including the lungs (pneumonia), blood (septicaemia), skin, other soft body parts (tissues), bone, and for infections such as meningitis and gonorrhoea (a sexually transmitted infection). It can be used to …

Continue Reading...
CLOSE
CLOSE